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Abstract: This study was conducted to
examine the autonomic nervous system
functions of obese people. The study group
consisted of 30 healthy obese people (20
female, 10 male, age range 18-58, median
37.6±9.7 years of age) and the control
group consisted of 30 healthy nonobese
people (18 female, 12 male, age range 1756, median 34.4±7.5 years). Each function
was tested by non-invasive applications
(orthostatic test, isometric exercise test,
Valsalva ratio test, 30/15 ratio test, heart
rate change test by deep respiration). The
results of the orthostatic test and isometric-
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Introduction
Despite wide fluctuations in physical activity and
caloric intake, body weight remains remarkably stable
over time in animals and humans, which suggests that
integrative control mechanisms couple energy
expenditure and food intake. A regulatory system that
maintains constant energy storage is likely to involve
complex interactions among humoral, neural, metabolic,
and psychological factors, and it has been suggested that
the Autonomic Nervous System (ANS) may be central in
the co-ordination of this system (1, 2). Many
experimental observations support this point of view. For
example,
experimentally
induced
ventromedial
hypothalamic lesions have been found to produce a
combination of decreased sympathetic activity, increased
parasympathetic activity and obesity (3). In several animal
models of spontaneous obesity, decreased sympathetic
activity has been noted (4). Parasympathetic blockade by
pharmacological means has been shown to influence
thermogenesis induced by food intake, and a relation has
been found between parasympathetic activity and total
energy storage in humans exogenously administered
sympathetic agonist has been shown to increase caloric
expenditure (1).

exercise test yielded a statistically significant
difference between the study and control
groups. The Valsalva ratio, 30/15 ratio, and
heart rate change with deep respiration tests
also demonstrated significant differences in
the study and in the control group.
The
results
indicate
characteristic
hypofunctional sympathetic autonomic
nervous system dysfunction in obese
subjects.
Key Words: Obesity, Autonomic Nervous
System.

Since the ANS is involved in energy metabolism and
the regulation of the cardiovascular system (5-7), it is
conceivable that one or more subgroups of persons with
idiopathic obesity have an alteration in their autonomic
nervous systems that may promote obesity, account for
several clinical consequences of obesity or protect against
certain health problems, such as sudden death or
hypertension. Therefore, ANS will be taken into
consideration more in the future in studies of the causes
and the results of human obesity. We studied the
relationship between ANS and obesity.
Materials and Methods
The study group consisted of 30 healthy obese
people, 20 female and 10 male. The mean age of the
subjects was 37.6±9.7 years (18-58 yrs).
Patients with the following histories were excluded
from the study: alcohol use, diabetes mellitus, cardiac
failure, cardiac arrhythmias, chronic obstructive lung
disease, psyhiatric disorders and head trauma with
concussion. In addition, patients with abnormal
laboratory test results (routine blood and urine analysis)
were also excluded from the study.
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Thirty nonobese healthy individuals similar to the
patients with regard to age and sex were selected for the
control group.
Written permission was obtained from every subject
before the study. Non invasive tests were conducted both
in the study and control groups, in order to evaluate ANS
functions in every subject.
In both groups, the orthostatic, Valsalva ratio, heart
rate change with deep respiration, 30/15 ratio and
isometric exercise tests were performed sequentially (710) in the same room with a constant temperature of 25
°C. Before the tests, all subjects rested in supine position
for a minimum of 15 minutes. ECG was recorded in
standard D2 derivations. Subjects rested for a minimum
of 2 minutes between tests. Blood pressure measures
were taken with standard sphygmomanometer.
To detect heart rate change with deep respiration
(HRCDR), heart rate was recorded first during normal
respiration (at rest), and then during deep respiration
(6/min). ECG 3rd and 6th respiration, minimum R-R
intervals and corresponding heart rate were calculated.
Maximum R-R intervals in normal respiration, and
corresponding heart rate were then calculated, and the
difference between both values was obtained.
Valsalva ratio: (PV/V) this is a test showing heart rate
change during the Valsalva Manoeuvre (forced expiration
when the glottis is closed) and gives valuable information
about autonomic control of heart rate. ECG records of
subjects were obtained over at least 20 sec in forced
expiration with an expiration pressure of 40 mmHg after
that test 20 sec normal expiration. During the test,
minimal R-R intervals were measured, and after the test,
maximal R-R intervals were measured. The ratio of post-

Age (year)
Weight (kg)
Body mass index (kg/m2)
Valsalva ratio
HRCDR
30:15 ratio
Orthostatic test (SBD)
Orthostatic test (DBD)
Isometric exercise test (SBD)

test R-R interval to test R-R interval was calculated as
post-Valsalva over Valsalva (PV/V).
30/15 ratio: after the subjects rose to erect posture
from supine position, the 30th and 15th heart beat R-R
interval was measured as corresponding heart rate ratio.
Orthostatic test: first, after the blood pressure of the
subjects in supine position was measured, they suddenly
rose to erect position. Starting from zero in the 1st and
2nd minutes, blood pressure was measured. Supine blood
pressure levels and the lowest erect blood pressure levels
were recorded (both systolic and diastolic), and
differences in systolic blood pressure (SBP) levels and
diastolic blood pressure (DBP) levels were calculated and
the obtained values were documented in mmHg.
Isometric exercise tests: subjects performed hand grip
at 30% of maximal effort capacity, for 5 minutes. Before
and after the exercise blood pressures were measured,
and the difference between both values was calculated.
All ECG recordings were performed by cardiofax
(Nihon Kohden corporation Tokyo-Japan).
Results of the study were expressed as
“mean±standard deviation” Statistical analysis was
performed by Student’s t-test.
Results
Some clinical characteristics of the study and of the
control group are shown in Table 1.
The weight of the study group was 92.17±13.29 kg,
and that of the control group was 59.70±9.06 kg. The
statistically significant difference between the groups was
(p<0.0001).

Study group (n=30)

Control group (n=30)

p

37.6±9.7
92.17±13.29
38.5±5.9
1.39±0.33
11.66±7.41
1.04±0.72
16.00±6.99
8.42±2.91
10.61±4.55

34.4±7.5
59.70±9.06
21.8±1.1
1.18±0.25
13.08±10.68
1.08±0.26
2.25±4.99
2.36±3.86
16.39±4.17

>0.05
<0.0001
<0.0001
>0.05
>0.05
>0.05
<0.0001
<0.0001
<0.05

HRCDR: Heart rate change with deep respiration, SBD: Systolic Blood Pressure differences
(mmHg), DBD: Diastolic Blood Pressure differences (mmHg).
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Table 1.

Some clinical parameters
in the study and control
groups.
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The body mass index (BMI) of the study group was
38.5±5.9 kg/m2, and that of the control group was
21.8±1.1 kg/m2. The statistically significant difference
between the groups was (p<0.0001).
Orthostatic test: the mean SBP of the study group in
supine position was 149.75±10.81 mmHg (130–170
mmHg), and that in erect position was 133.75±13.36
mmHg (105-150 mmHg). The difference between the
two values was calculated as 16.00±6.99 mmHg. The
mean DBE in supine position was 78.00±7.84 mmHg
(70–100 mmHg), and that in erect position was
69.50±7.23 mmHg (60-90 mmHg). The difference
between the two values was calculated as 8.42±2.91
mmHg.
The mean SBP of the control group in supine position
was 114.25±11.84 mmHg, and that in erect position
was 111.50±11.25 mmHg (80–130 mmHg). The
difference between the two values was 2.25±4.99
mmHg. The mean DBP of the control group in supine
position was 71.25±9.01 mmHg (50-80 mmHg), and
that in erect position was 69.00±10.20 mmHg (50-80
mmHg). The diffference between the two values was
2.36±3.86 mmHg.
In erect position and supine position, the difference in
SBP in the study group (16.00±6.99 mmHg) was higher
than in the control group (2.25±4.99 mmHg). The
difference between two groups was statistically
significant (p<0.001).
In erect position and supine position, the difference in
DBP in the study group (8.42±2.91 mmHg) was higher
than in the control group (2.36±3.86 mmHg). The
difference was statistically significant (p<0.0001).
The valsalva ratio was somewhat higher in the study
group (1.39±0.33) than in the control group
(1.18±0.25), although the difference was not significant
(p>0.05).
The 30:15 ratio was 1.04±0.72 in the study group
and 1.08±0.26 in the control group. The difference was
not significant (p>0.05).
Heart rate change with deep respiration was
11.66±7.41 in the study group, and 13.08±10.68 in the
control group. The difference was not significant
(p>0.05).
The SBP change with isometric exercise was
10.61±4.50 mmHg in the study group, and 16.39±4.17
mmHg in the control group. The difference was
statistically significant (p<0.05).

The DBP change with isometric exercise was
7.31±6.50 mmHg in the study group, 6.92±4.43 mmHg
in the control group. And the difference between the
values was not significant (p>0.05).
Discussion
Obesity, a common and significant health hazard, is
associated with an increased incidence of hypertension,
congestive heart failure, and unexplained sudden death,
as well as an overall increase in mortality rate (11, 12).
In the studies about the relationship between total
mortality and the obesity, it is clearly seen that when the
body mass index reaches 30 kg/m2, mortality incidence
increases dramatically (13). Nevertheless, the causes of
most cases of human obesity are still unknown (14). Body
weight and the level of stored calories in humans and
animals remain constant over long periods of time,
suggesting that integrative control mechanisms couple
energy expenditure and food intake. A regulatory system
that maintains constant energy storage is likely to involve
complex interactions among humoral, neural, metabolic,
and psychological factors, and it has been suggested that
the ANS may be central in the coordinatiton of this system
(1, 2, 15).
Orthostatic and isometric exercise tests were used in
the study are for the evaluation of the sympathetic
nervous system functions. Both tests showed a decrease
in the hypofunctional sympathetic system. There were no
statistically significant differences between the control
and study groups in the results of Valsalva ratio, HRCDR
and 30/16 ratio, which evaluate parasympathetic nervous
system activity.
Our findings revealed hypofonctional sympathetic ANS
dysfunction in the study group. In the literature, some
studies have shown increased caloric expenditure by
exogenously sympathetic agonist administration,
parasympathetic blockade by pharmacological means has
been shown to influence thermogenesis induced by food
intake, and a relation has been found between
parasympathetic activity and total energy storage in
humans (1), and a decrease in the sympathetic activity
with an increase in body fat percentage (7). With a
reduction of caloric intake there can be a prompt and
major decline in sympathetic activity, although an increase
in sympathoadrenal activity has also been documented
(16, 17). In several animal models of spontaneous
obesity, decreased sympathetic activity has been noted
(4). Experimentally induced ventromedial hypothalamic
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lesions have produced a combination of decreased
sympathetic activity, increased parasympathetic activity
and obesity (3). In obese animals, the decrease in
sympathetic activity may lead to an increase in
hypogenesis, and a decrease in lypolisis, as well as
excessive energy storage (16).

Sympathetic acitvity decrease may be the primary reason
for excessive energy storage, or it may be the reflection
of any other unknown factor of factors.

The findings of our study are similar to some human
studies and obese animal models in respect to
sympathetic activity decrease (1, 3, 4, 7, 16).

In conclusion, obesity, a risk factor for health, and its
complications can be coped with by diagnosing and
treting ANS dysfunction.

In obese persons, serious health problems may be
seen if current ANS stress increases. This may not be
compensated (7).
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